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Abstract
 
Immature bone marrow–derived myeloid dendritic cells (BMDCs) are induced to undergo
 
phenotypic maturation and secretion of tumor necrosis factor (TNF)-
 
 
 
, interleukin (IL)-6, IL-12,
 
and IL-10 when pulsed in vitro with intact 
 
Streptococcus pneumoniae
 
. After transfer to naive mice,
pulsed BMDCs induce immunoglobulin (Ig) isotype responses specific for both protein and
 
polysaccharide pneumococcal antigens, having in common the requirement for viable BMDCs,
T cells, and B7-dependent costimulation in the recipient mice. Whereas primary Ig isotype re-
sponses to bacterial proteins uniformly require BMDC expression of major histocompatibility
complex class II, CD40, and B7, and the secretion of IL-6, but not IL-12, similar requirements
for antipolysaccharide Ig responses were only observed for the IgG1 isotype.
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Introduction
 
Two major categories of antigen have been recognized,
thymus-dependent (TD)
 
*
 
 and thymus-independent (TI)
antigens, based on their relative ability to induce Ig anti-
body responses in athymic nude mice, which are markedly
deficient in T cells (1). TI antigens, such as bacterial
polysaccharides are unable to bind to MHC molecules (2)
and hence cannot directly trigger cognate interactions be-
tween APCs and T cells. These observations suggested a
minimal, if any, role for APCs and T cells in humoral im-
mune responses to polysaccharide antigens. The presence
of repeating, identical antigenic epitopes expressed by
polysaccharide molecules suggested instead, that they di-
rectly mediated B cell activation through potent membrane
Ig-mediated activation which in concert with some form of
nonT cell help induced Ig secretion (3). However, consid-
erable evidence has accumulated indicating that T cells,
acting in a noncognate manner, can play a significant role
 
in regulating specific antibody responses to bacterial polysac-
charides (1, 4–7). Nevertheless, little is known regarding
the potential role of APCs in these responses. Only in vitro
studies describing a direct role of macrophages in B cell ac-
tivation in response to TNP-haptenated antigens such as
TNP-Ficoll, TNP-LP, and TNP-
 
Brucella abortus
 
, have been
reported (8, 9).
 
Dendritic cells (DCs) are APCs with the unique property
of inducing primary immune responses, thus allowing estab-
lishment of immunological memory (10). Immature DCs in
peripheral tissues, internalize (11, 12) and process bacteria
and other particulate antigens for MHC class I and MHC
class II antigen presentation to T cells (13), migrating to sec-
ondary lymphoid organs, where DCs prime naive T cells
(14, 15), naive and memory B cells (16, 17) and activate NK
cells (18) to induce specific immune responses. A role for
DCs in conferring antimicrobial immunity is suggested by
studies in which in vitro antigen-pulsed DCs transferred into
naive hosts conferred protection against a further challenge
with the pathogen (19, 20). These observations indicate that
DCs play a key role in linking innate and adaptative immu-
nity, critical for host protection against microbial pathogens.
Protection against extracellular bacteria is largely con-
ferred by Ig specific for bacterial polysaccharide and protein
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Dendritic Cells Induce Polysaccharide-specific Ig Responses
 
antigens (21). We demonstrated previously the ability of
the Gram-positive extracellular bacteria, 
 
Streptococcus pneu-
moniae
 
, to induce polysaccharide- and protein-specific Ig
isotype responses in vivo, in which both responses were
dependent on T cell help and B7-dependent costimulation
(6, 22). On the basis of these data we wished to determine
a potential role for DCs in these responses. Using immature
myeloid DCs transferred to naive mice after in vitro pulsing
with 
 
S. pneumoniae
 
, we demonstrate for the first time the
ability of DCs to initiate in vivo humoral responses to “TI”
antigens, expressed by an intact extracellular bacteria, and
underscore striking differential DC requirements for induc-
tion of protein- versus polysaccharide-specific responses.
 
Materials and Methods
 
Mice.
 
C57BL/6N mice were obtained from the National
Cancer Institute. IL-6
 
 
 
/
 
 
 
, IL-10
 
 
 
/
 
 
 
, IL-12
 
 
 
/
 
 
 
, CD40
 
 
 
/
 
 
 
, MHC
class II
 
 
 
/
 
 
 
 (locus Ma) mice and their corresponding C57BL/6J
controls were obtained from The Jackson Laboratory.
B6129SF2/J mice were used as controls for the TNF-
 
 
 
 
 
/
 
 
 
 mice
both obtained also from The Jackson Laboratory. Double B7–
1
 
 
 
/
 
 
 
  
 
 B7–2
 
 
 
/
 
 
 
 (CD80/CD86) mice and the corresponding
BALB/c controls were provided by Arlene Sharpe (Brigham and
Women’s Hospital, Boston, MA). Mice were used at 8–10 wk of
age and were maintained in a pathogen-free environment at Uni-
formed Services University of the Health Sciences (USUHS).
 
Cell Culture Media.
 
The cell culture media consisted of
RPMI 1640 supplemented with 5% FCS (Bio Wittaker), 50 
 
 
 
M
2-ME, 20 
 
 
 
g/ml gentamycin, 1 mM sodium pyruvate, 2 mM
 
L
 
-glutamine, 0.1 mM nonessential amino acids, and 25 mM Hepes.
 
S. pneumoniae Strains and Bacterial Antigens.
 
The 
 
S. pneumo-
niae
 
 capsular type 14 was provided by Mr. Sam Wilson
(USUHS). The capsular type 3 strain WU-2, the stable nonen-
capsulated variant JD6/11 of this strain (23), and the nonencap-
sulated variant R36A of type 2 were all gifts of David E. Briles
(University of Alabama, Birmingham, AL). Recombinant pneu-
mococcal surface protein A (PspA), a gift of Luba Grinberg (Bio-
synexus, Inc., Rockville, MD), was expressed in 
 
Saccharomyces cer-
evisiae
 
 BJ3505 as a His
 
6
 
-tagged fusion protein, and purified by
Ni-NTA affinity chromatography (24). Recombinant pneumo-
coccal surface adhesion A (PsaA), provided by James C. Paton
(Adelaide University, Adelaide, Australia), was expressed in
 
Escherichia coli
 
 as a His
 
6
 
-tagged fusion protein, and purified by
Ni-NTA affinity chromatography (25). Phosphorylcholine (PC)-
KLH, a gift of Andrew Lees (Biosynexus, Inc.), was synthesized
as described previously (6). The resulting conjugate had a substi-
tution degree of 19 PC/KLH molecule. Purified capsular
polysaccharide type 14 (Cps14) was purchased from American
Type Culture Collection.
 
Bacterial Culture and Preparation of the Bacterial Inoculum.
 
Iso-
lated colonies in Columbia blood agar were grown in Todd
Hewitt broth to mid-log phase, collected, and heat killed by in-
cubation at 60
 
 
 
C for 1 h. Sterility was confirmed by subculture
on blood agar plates. After extensive washings, the bacterial sus-
pension was adjusted with PBS to give an absorbance reading at
650 nm of 0.6 which corresponded to 10
 
9 
 
CFU/ml. Bacteria
were then aliquoted at 10
 
10
 
 CFU/ml and frozen at 
 
 
 
80
 
 
 
C until
their use as antigen for mouse immunizations or to pulse bone
marrow–derived myeloid dendritic cells (BMDCs) in culture.
Bacteria treated with 0.1% paraformaldehyde for 16 h at 20
 
 
 
C,
 
were preserved and aliquoted similar to heat-killed bacteria, and
were used in a preliminary set of experiments.
 
Fluorescent Labeling of S. pneumoniae with CM-DiI.
 
Bacteria
were labeled with the fluorescent lipophilic cell tracer chloro-
methylbenzamido derivative of DiI (CM-DiI; Molecular Probes).
Specifically, suspensions of 10
 
9
 
 bacteria per milliliter were incu-
bated at 37
 
 
 
C for 10 min, in a solution containing 5 mM CM-
DiI in PBS. The suspension was then incubated for an additional
30 min at 4
 
 
 
C. After the incubation, the excess of fluorescent
tracer was removed by extensive washings in cell culture media.
 
BM Cell Culture.
 
DCs were cultured from bone marrow, es-
sentially as described previously (26), with slight modifications.
Briefly, bone marrow was flushed from femurs and tibia, homog-
enized and the red blood cells removed by lysis with ACK lysing
buffer (GIBCO BRL). T cells, B cells, and other MHC class II–
expressing cells were removed from the bone marrow cell sus-
pension by incubation for 30 min at 4
 
 
 
C with a mAb cocktail
composed by AF6–120.1 (mouse IgG2a
 
 
 
 anti-I-A
 
b
 
), RA3–6B2
(rat IgG2a
 
 
 
 anti-CD45R/B220), and 53–5.8 (rat IgG1
 
 
 
 anti-
CD8b.2), and negatively selected by magnetic bead cell sorting
using a mixture of affinity purified polyclonal goat anti–rat IgG
and goat anti–mouse IgG-conjugated beads (BioSpheres). All the
mAbs were purchased from BD PharMingen. The BM cells ob-
tained were cultured at 1.25 
 
 
 
 10
 
6
 
 cells per milliliter in cell cul-
ture media supplemented with 10 ng/ml of murine recombinant
GM-CSF, provided by Luba Grinberg. The cells were cultured at
37
 
 
 
C in an atmosphere of 7% CO
 
2
 
 and 95% humidity. On day 3
the supernatant was removed and replaced with fresh media con-
taining GM-CSF. On day 5, 
 
 
 
2/3 of the supernatant was
removed, replaced with 2 volumes of fresh media containing
GM-CSF, and the cultures were split into two wells. Typical ex-
periments were performed with the nonadherent and loosely ad-
herent cell population from cultures at days 6–8. At the end of
the culture period, 
 
 
 
95% of the cells displayed the morphology
and cell surface markers characteristic of myeloid DCs.
 
Flow Cytometric Analysis of BMDC Surface Antigen Expression.
 
All steps were performed on ice. For staining BMDCs for flow
cytometry, the Fc receptors were specifically blocked with 2.5
 
 
 
g/ml/10
 
6
 
 BMDCs of anti-CD16/CD32 mAb (clone 2.4G2;
BD PharMingen) in PBS containing 1% FCS (staining buffer), 45
min before the staining, and during the staining. Cells were
stained by incubation for 30 min with biotinylated or PE-conju-
gated mAbs (BD PharMingen) specific for CD11c (clone HL3),
CD8
 
 
 
 (clone 53–6.7), CD11b (M1/70), I-A
 
b
 
 (clone AF6–120.1),
I-A
 
d
 
 (clone AMS-32.1), H2-K
 
b
 
 (AF6–88.5), H2-K
 
d
 
 (SF1–1.1),
CD40 (clone 3/23), CD80 (16–10A1), CD86 (clone GL1),
CD25 (clone PC61), and CD54 (clone 3E2). The incubation
with biotinylated mAbs was followed by staining with PE-
streptavidin conjugate for 15 min. For detection of CD16/CD32
expression with the specific antibody (clone 2.4G2), the Fc
blocking step was omitted. Irrelevant isotype and species-
matched mAbs were used as staining controls. Cells were ana-
lyzed on an EPICS XL-MCL (Beckman Coulter). Dead cells and
debris were excluded from analysis by gating on the appropriate
forward and side scatter profile.
For detection of PC on the surface of pulsed BMDCs, the Fc
receptor-blocked cells were directly stained with FITC-conju-
gated murine IgM (clone HPCM2) or IgG2a (clone G2a2.A1)
anti-PC mAbs, or indirectly with unconjugated IgG2b (clone
1B8E5) followed by staining with FITC-conjugated rat anti–
mouse IgG2b mAb (clone R12–3; BD PharMingen). For detec-
tion of intracellular PC, pulsed BMDCs were fixed and per-
meabilized with Cytofix/Cytoperm Plus (BD PharMingen) 
3
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according to manufacturer’s instructions, and stained with FITC-
conjugated murine IgG2a anti-PC (clone G2a2.A1). The PC-
specific mAbs were gifts of Anna Lusting and James J. Kenny
(National Institutes of Health). The specificity of the mAbs were
confirmed by ELISA. A similar indirect approach using mouse
polyclonal antibodies to Cps14 followed by staining with FITC-
conjugated rat anti–mouse IgG2b mAb or PE-conjugated poly-
clonal goat anti–mouse IgM (Southern Biotechnology Associates,
Inc.) were used to detect surface Cps14. Controls included pulsed
BMDCs stained with FITC-conjugated murine IgM anti-TNP
mAb (G155–228) or FITC-conjugated murine IgG2a anti-TNP
mAb (G155–178), and for indirect stainings purified IgG2b anti–
mouse IgD
 
a
 
 (AMS9.1). Staining of free 
 
S. pneumoniae
 
 analyzed in
the same way was used as a positive control.
 
Bacterial Pulsing of BMDCs for In Vivo Transfer Experiments.
 
BMDCs collected after 6–8 d of culture were washed two times
in cell culture media. Residual macrophages were removed
through plastic adherence during 1 h of culture at 37
 
 
 
C. BMDCs
were plated at 10
 
6
 
 BMDCs per milliliter per well in 24-well cell
culture plates (Costar). After 30 min, to allow cells to settle, 100
 
 
 
l of a bacterial suspension in cell culture media containing the
desired amount of inactivated 
 
S. pneumoniae
 
 was added to the cul-
tures. In experiments involving transfer of in vitro–pulsed BM-
DCs into naive mice, the BMDCs were pulsed at ratios of 800
bacteria per individual BMDCs during a time pulse of 4–5 h in
media containing GM-CSF. After the pulse, the excess of bacteria
was extensively washed, at least six times each for 10 min at 350
 
  
 
g
 
at 4
 
 
 
C. A control tube containing a mixture of thymocytes and
CM-DiI fluorescent labeled-
 
S. pneumoniae
 
 at the same bacterial
density as at the onset of BMDC pulsing was used to monitor the
progress of the washings. If 
 
 
 
100 free bacteria were found in the
resulting examination of the pelleted cells in an inverted fluores-
cent microscope, the washings were continued. The pulsed
BMDC pellet obtained was resuspended in fresh cell culture me-
dia at a final density of 0.5 
 
 
 
 10
 
7
 
 BMDCs per milliliter and doses
of 200 
 
 
 
l (10
 
6
 
 BMDCs) were intravenously injected into the
mice. To test the immunogenicity of the phagocyted bacteria by
themselves, half of the pulsed BMDCs preparation ready for im-
munization, was subjected to three sequential freeze-thaw cycles
performed by immersion in liquid nitrogen and thaw at 37
 
 
 
C. No
further washings were performed before immunization (in order
to retain the released bacterial products during the freeze-thaw
cycles).
For viability experiments, immediately after the pulse and after
extensive washing performed at 4
 
 
 
C, pulsed BMDCs were fixed
for 30 min in 1% paraformaldehyde in PBS at RT or for 1 min in
70% ethanol in PBS. Cells were washed again three times and the
viability and cell count determined before injection.
 
Phagocytic Capacity of BMDCs.
 
BMDCs were pulsed with
varying ratios of CM-DiI–labeled 
 
S. pneumoniae
 
/DC as indicated
above for the transfer experiments. At different times (0, 0.5, 5,
and 24 h), the BMDCs were collected, washed in PBS, and viable
BMDCs were analyzed by flow cytometry gating to exclude free
bacteria by size. BMDCs pulsed with unlabeled bacteria at the
same ratios were used to estimate the background of nonspecific
fluorescence. To estimate the average maximal number of bacte-
ria phagocytosed per individual BMDC, the mean fluorescence
intensity (MFI) of the gated BMDCs pulsed with CM-DiI–
labeled bacteria, after subtracting background fluorescence, was
divided by the MFI of the CM-DiI–labeled free bacteria used for
the pulse. Because CM-DiI is lipophilic, an increased fluores-
cence emission due to the aggregation of the labeled particles af-
ter DC internalization, and due to label insertion in DC mem-
 
branes as a result of bacterial processing by the DCs could be
expected. Thus, the obtained value must be considered as maxi-
mal average uptake.
 
Cytokine ELISA.
 
The concentrations of specific cytokines
released into the media of BMDC cultures were measured using
optimized standard sandwich ELISA. Recombinant cytokines
used as standards, as well as the capture mAbs, biotinylated mAbs
used for detection, and streptavidin-alkaline phosphatase (AP)
were purchased from BD PharMingen. Streptavidin-AP was used
in combination with PNPP (p-nitrophenyl phosphate disodium;
Sigma-Aldrich) as substrate to detect the specific binding. Stan-
dards were included in every plate and the samples were tested in
duplicate. The detection limits of the respective ELISAs were 20
pg/ml IL-2, 35 pg/ml IL-3, 5 pg/ml sIL-4, 4 pg/ml IL-6, 150
pg/ml IL-10, 6 pg/ml IL-12 (p40/p70), 125 pg/ml IL-12 (p70),
12 pg/ml TNF-
 
 
 
, and 80 pg/ml IFN-
 
 
 
.
 
 “Real-Time” RT-PCR for Measurement of Cytokine-specific
mRNA.
 
Total RNA was extracted from BMDCs, collected at
different times during the pulse with 
 
S. pneumoniae
 
 using RNAzol B
(TEL-TEST, Inc.). Control samples included mRNA obtained
from BMDCs cultured for the same time period in medium
alone. Total RNA was then reversed-transcribed using the Su-
perscript II Preamplification System for first strand cDNA synthe-
sis (Invitrogen) according to manufacturer’s instructions. 180 ng
RNA was subsequently used as template for each “Real-Time”
PCR reaction. All PCR reactions for cytokine-specific mRNA
were performed on an ABI PRISM 7700 Sequence Detector Sys-
tem (PE Applied Biosystems) using proprietary cytokine-specific
primers and probes from ABI Applied Biosystems. Relative cyto-
kine mRNA levels were determined by normalization of signal
with that for ribosomal RNA. In initial studies, twofold dilutions
of cDNA generated a linear signal curve over at least a 30-fold
range of cDNA concentrations. mRNA induction in pulsed BM-
DCs was reported as -fold increases over BMDCs cultured in me-
dium alone.
 
Protocols for Immunization and Cell Transfer.
 
Mice were im-
munized intraperitoneally with 5 
 
 
 
 10
 
6
 
 free, heat-killed 
 
S. pneu-
moniae
 
 in PBS, or injected intravenously with 10
 
6
 
 viable BMDCs.
For in vivo Ig induction studies using pulsed BMDCs obtained
from wild-type versus knockout mice, serum samples were ob-
tained 14 d after BMDCs transfer into naive wild-type mice.
 
In Vivo T Cell Depletion and B7 Blockade.
 
For acute depletion
of T cells, mice were injected intravenously with 1 mg each of
purified rat IgG2b anti–mouse CD4 (clone GK1.5) and rat IgG2b
anti–mouse CD8 (clone 2.43) mAbs 2 d before the injection with
BMDCs. Control mice received 2 mg of purified rat IgG2b mAb
(J1.2) of irrelevant specificity. In vivo blockade of B7 interactions
was accomplished through intravenous injection, 1 d before im-
munization, of 0.2 mg of a murine fusion protein of cytotoxic T
lymphocyte antigen (CTLA)-4 and an Ig domain (CTLA4Ig)
provided by William C. Gause (USUHS). Control mice received
0.2 mg of L6, a control fusion protein. The effects of these treat-
ments has been reported previously in detail (6, 27).
 
Measurement of Serum Titers of Ig Isotypes Specific to Cps14, PC,
and PspA by ELISA.
 
Immulon-4 HBX (Dynex Technologies)
microtiter plates were coated with 0.5 
 
 
 
g/well of Cps14 in 0.1 M
bicarbonate buffer, pH 9.6, overnight at 4
 
 
 
C. After the plates
were washed four times in 0.1 M Tris, pH 8.3, containing 0.05%
Tween 20 and 5% ovalbumin (EBTA), threefold dilutions of the
serum samples diluted in EBTA were then added starting at 1/10
or 1/25, and the plates incubated overnight at 4
 
 
 
C. The plates
were washed three times with EBTA and incubated during 1 h at
37
 
 
 
C with polyclonal goat anti–mouse IgM, IgG1, IgG2a, 
4
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IgG2b, or IgG3 conjugated to AP. Plates were washed five times
with PBS containing 0.05% Tween 20, and the enzymatic reac-
tion developed for 2 h at RT using as substrate, 1 mg/ml solution
of PNPP in 1 M Tris-ClH buffer, pH 9.8, and 0.3 mM MgCl
 
2
 
.
In every plate was included one high titer antisera pool as stan-
dard to normalize the interassay results. Titers were expressed as
the dilution of sera giving an absorbance at 405 nm equal to 1.0.
If the absorbances obtained were under 1 the titer was extrapo-
lated from the standard curve.
The ELISAs for the measurement of PC and PspA-specific Ig
isotype titers have been reported previously (6). Briefly, Immu-
nolon 4 HBX immunoplates were coated overnight with 0.5 
 
 
 
g/
well of PC-KLH or recombinant PspA in PBS at 4
 
 
 
C. The plates
were washed in PBS containing 0.05% Tween 20 and unspecific
binding blocked with PBS containing 2% BSA. The protocols
were similar to those described for detection of Cps14-specific Ig.
 
Statistics.
 
Data were expressed as arithmetic mean 
 
 
 
 SEM of
the individual titer. Levels of significance of the differences be-
tween groups were determined by the Student’s 
 
t
 
 test. 
 
P
 
 values
 
 
 
0.05 were considered statistically significant.
 
Results
 
Internalization of Heat-killed S. pneumoniae by Cultured
BMDCs Is Essentially Nonsaturable.
 
To determine a po-
tential role of DCs in mediating protein- and polysaccha-
ride-specific Ig isotype responses to 
 
S. pneumoniae
 
 we pre-
pared a relatively pure population of DCs by culturing
preselected BM cells in GM-CSF. After 6–8 d of culture
we obtained a 
 
 
 
95% population of cells with a morphol-
ogy (data not shown) and cell surface phenotype (Fig. 1 C)
consistent with immature myeloid (CD11c , CD11b ,
CD8  ) DCs (28). We first wished to determine the aver-
age rate of DC uptake of CM-DiI–labeled S. pneumoniae as
a function of bacterial density. As is shown in Fig. 1 A, up-
take of nonopsonized S. pneumoniae (nonencapsulated vari-
ant of capsular type 3, JD6/11) by cultured BMDCs was
essentially nonsaturable. Similar kinetics of uptake as a
function of bacterial density were also obtained with en-
capsulated (type 3 or type 14) or nonencapsulated (type 2)
strains (data not shown). At the higher bacterial densities a
plateau in uptake was observed after a prolonged culture
period ( 24 h) (Fig. 1 A), most likely due to the decrease
in uptake of bacteria that is typically associated with DC
maturation (Fig. 1 C).
S. pneumoniae Induces BMDCs to Secrete TNF- , IL-6,
IL-12, and IL-10 with Different Kinetics. BMDCs consti-
tutively secreted relative low levels of IL-12 (p40/p70)
(210   25 pg/ml) during the culture period, but released
no detectable TNF-  ( 12 pg/ml), IL-6 ( 4 pg/ml), IL-
10 ( 150 pg/ml), IL-2 ( 20 pg/ml), IL-3 ( 70 pg/ml),
IL-4 ( 5 pg/ml), or IFN-  ( 80 pg/ml). Stimulation with
S. pneumoniae induced BMDCs to secrete TNF- , IL-6,
IL-12, and IL-10 with distinct kinetics (Fig. 1 B), but did
not stimulate detectable IL-2, IL-3, IL-4, or IFN- . TNF- 
was the first to be detected (30 min) after exposure to S.
pneumoniae followed closely by IL-6 and IL-12 (1–2 h) then
later by IL-10 (5 h) (Fig. 1 B). Detection of IL-12 as p40/
p70 or p70 resulted in similar kinetics (data not show). In
pulse-chase experiments (Fig. 1 B) we observed a rapid
downregulation of TNF-  secretion. After 5 h no further
secretion of TNF-  could be detected. Secretion of IL-12
and IL-10 dropped significantly after 5 h but was still de-
tectable for an extended period (up to 24 h). In contrast,
IL-6 secretion was sustained for  48 h at levels 1,000 
over the background (Fig. 1 B, data not shown). The ki-
Figure 1. S. pneumoniae uptake
and BMDC responses to S. pneu-
moniae in vitro. (A) Time course
of internalization of heat-killed
S. pneumoniae (JD6/11 strain) la-
beled with the fluorescent tracer
CM-DiI, at the bacteria: BMDC
ratios indicated. The dotted line
shows the estimated MFI pro-
duced by internalization of one
diplococcus. (B) Concentrations
of cytokine released into the me-
dia (left) or cytokine mRNA
synthesis (middle) at varying
times after addition of S. pneumo-
niae type 14, or during a 20-h pe-
riod in the absence of bacteria af-
ter exposure to free bacteria for
different times (right). (C) S.
pneumoniae triggering of BMDC
maturation. FACS® analysis of
BMDC phenotype after culture
for 20 h in the absence ( ) or in
the presence ( ) of 800 heat-
killed S. pneumoniae per individ-
ual BMDCs. Dotted histograms
represent cells stained with iso-
type-matched control mAbs. The
data shown is representative of
three independent experiments.5 Colino et al.
netics of cytokine secretion correlated well with the kinet-
ics of induction of cytokine-specific mRNA (Fig. 1 B).
These data strongly suggest that S. pneumoniae induces,
with distinct kinetics, transcriptional upregulation and se-
cretion of both proinflammatory (IL-6, IL-12, and TNF- )
and antiinflammatory (IL-10) cytokines by BMDCs.
S. pneumoniae Induces Maturation of BMDCs in Culture.
As shown in Fig. 1 C, S. pneumoniae also induced BMDC
maturation in vitro, as evidenced by upregulation of MHC
class II, CD40, CD80 (B7–1), CD86 (B7–2), and CD25
(IL-2R ), and downregulation of CD16/CD32 (Fc  II/III
receptor). The expression levels of CD11c, CD11b, and
H2-K were unchanged after S. pneumoniae exposure,
whereas CD8  was undetectable at all time points. The in-
duction of BMDC maturation was dose–dependent with
little phenotypic change occurring at 40 bacteria/DC, thus
establishing a stimulation threshold for this process. In
pulse-chase experiments, optimal induction of BMDC
maturation required no more than 2–5 h exposure to S.
pneumoniae (data not shown).
BMDCs Pulsed In Vitro with S. pneumoniae Induced both
Protein- and Polysaccharide-specific Ig Isotype Responses In Vivo.
In preliminary experiments we established a set of condi-
tions for inducing optimal in vivo protein- and polysaccha-
ride-specific Ig responses upon transfer of S. pneumoniae-
pulsed DCs (“pulsed BMDCs”) into naive mice (data not
shown). On the basis of these studies, we chose to inject
each mouse intravenously with 106 viable BMDCs that
were pulsed with a ratio of 800 bacteria per individual DC
for a 4–5 h period. This resulted in each DC internalizing
an average of  10 bacteria (see Fig. 1 A). As illustrated
above, these conditions for BMDCs pulsing further al-
lowed for in vitro autocrine/paracrine exposure of BMDCs
to stimulatory cytokines, but without significant exposure
to immunosuppressive IL-10, and for continued cytokine
secretion, with the exception of TNF- , by BMDCs upon
transfer in vivo. As shown in Fig. 2, BMDCs pulsed with
heat-killed S. pneumoniae and transferred into naive mice
stimulated a primary Ig response specific for PspA, Cps14,
and PC (hapten component of the cell wall C-polysaccha-
ride). BMDCs pulsed with formalinized bacteria induced
comparable primary antigen-specific Ig responses (data not
shown). A primary Ig response specific for PsaA, a mem-
brane-bound lipoprotein, was also induced (data not
shown). In contrast, unpulsed BMDCs failed to induce any
specific primary Ig response.
The kinetic and isotype distribution of the primary hu-
moral responses induced by pulsed BMDCs were generally
similar to that observed after immunization with free S.
pneumoniae (Fig. 2). The Ig isotype profiles were dependent
on the eliciting antigen. PspA-specific Igs were dominated
by IgG2b and IgG2a, with lower amounts of IgG1. No
PspA-specific IgA, IgM, or IgG3 were detected. In con-
trast, polysaccharide-specific responses (anti-PC and anti-
Cps14) included all Ig isotypes, but IgM and IgG3 were
prevalent. The primary anti-PC response displayed kinetics
characteristic of a classical TI response with Ig levels peak-
ing around day 7. However, the primary anti-Cps14 re-
sponse showed more delayed kinetics similar to those ex-
hibited by the PspA-specific Ig response (Fig. 2).
Mice Primed with S. pneumoniae–pulsed BMDCs Developed
Immunological Memory. The anti-PspA response elicited by
pulsed BMDCs was highly boosted for all Ig isotypes after
secondary immunization with a suboptimal dose of free
Figure 2. Kinetics of the in vivo antiprotein and anti-
polysaccharide Ig isotype induced by in vivo transfer of
BMDCs pulsed with S. pneumoniae type 14. Groups of
C57BL/6 mice (n   6) received an intravenous injection
of 106 BMDCs pulsed with S. pneumoniae type 14 (black
symbols) or 106 unpulsed BMDCs as control (white sym-
bols) at day 0. At day 21, both groups of mice received an
intraperitoneal immunization with 5   106 free S. pneumo-
niae type 14 (indicated by arrows). The data shows the se-
rum titers of Ig isotypes specific for PspA (top), PC (mid-
dle), and Cps14 (bottom) on different days after
immunization. The data shown are representative of two
independent experiments.6 Dendritic Cells Induce Polysaccharide-specific Ig Responses
bacteria (17–19-fold enhancements) (Fig. 2). In contrast,
mice receiving unpulsed BMDCs followed by immuniza-
tion with free bacteria elicited a barely detectable anti-PspA
response. These data indicated that pulsed BMDCs induced
PspA-specific memory. In contrast, the IgM, IgG3, and
IgG2b anti-PC responses in mice receiving pulsed or un-
pulsed BMDCs were equivalent after boosting with free
bacteria. An exception was IgG1 anti-PC which was  10-
fold higher in boosted mice receiving pulsed versus un-
pulsed BMDCs (Fig. 2). Mice receiving two immuniza-
tions (21 d apart) with free bacteria alone, showed no
boosted anti-PC responses for any isotype, arguing against
significant carry-over of free bacteria during primary im-
munization with pulsed BMDCs. The ability to similarly
boost the anti-Cps14 response in mice receiving pulsed
BMDCs was also Ig isotype-dependent (Fig. 2). Thus, sig-
nificant boosting was again seen for the IgG1 isotype, but
also for IgG3, whereas little if any boosting was observed
for IgM or IgG2b anti-Cps14 relative to mice receiving
unpulsed BMDCs. Collectively, these data indicate the
ability of BMDCs pulsed with intact S. pneumoniae to uni-
formly elicit strong immunologic memory for a bacterial
protein. Memory generation for an antipolysaccharide re-
sponse was Ig isotype dependent.
Viable Pulsed BMDCs Are Specifically Required for Induction
of Ig Responses In Vivo. We next wished to determine
whether pulsed DCs played an active role in initiating in
vivo Ig responses, or perhaps were serving as nonspecific
and passive carriers of antigen. Thus, BMDCs were first
pulsed with S. pneumoniae type 14, then the excess of bac-
teria was washed and immediately fixed in formaldehyde
before transfer into naive mice. As shown in Fig. 3, BM-
DCs viability was critical for both anti-PspA and anti-
polysaccharide Ig responses. Similar results were obtained
when BMDCs were pulsed with the nonencapsulated
R36A strain, then fixed in ethanol before transfer (data not
shown). The Ig induction was specific for BMDCs since
viable thymocytes incubated with bacteria also failed to in-
duce detectable antigen-specific Ig responses (Fig. 3), ruling
out the possibility that carry-over of free bacteria was re-
sponsible for the observed Ig responses in vivo. Moreover,
immunization with BMDCs which were first pulsed with
S. pneumoniae, then freeze-thawed immediately before in-
jection, did not induce detectable antiprotein- or anti-
polysaccharide-specific Ig responses (Fig. 4). These data
strongly suggest that internalized bacteria, in the absence of
viable BMDCs, were not immunogenic by themselves.
Collectively, these data demonstrate an active role for
pulsed BMDCs in mediating both protein- and polysaccha-
ride-specific Ig responses in vivo.
Both Antiprotein and Antipolysaccharide Ig Responses Induced
by Pulsed BMDCs Are T Cell-dependent and Require B7-
dependent Costimulation. To determine the requirement
for T cells in mediating Ig responses to pulsed-BMDCs we
acutely depleted T cells in the recipient mice with anti-
CD4 and anti-CD8 mAbs before injecting pulsed BMDCs.
As shown in Fig. 5, endogenous T cells were critical for
development of IgG specific for both anti-PspA and
polysaccharide antigens, whereas IgM antipolysaccharide
responses showed only a partial dependence on T cells. We
further wished to determine whether B7-dependent co-
stimulation was required for these T cell–dependent effects.
Mice were therefore injected with CTLA4Ig before trans-
fer of S. pneumoniae-pulsed BMDCs. As shown in Fig. 5,
functional interaction of T cells with B7 expressed on ei-
ther recipient cells and/or on the injected BMDCs pulsed
with S. pneumoniae, were critical for both the IgG anti-
PspA and IgG anti-Cps14 responses. Significant suppres-
Figure 3. BMDCs viability is critical for
the induction of antigen-specific antibody
responses. Groups of five B6.129 mice were
injected intravenous with either 106 viable
BMDCs pulsed with S. pneumoniae type 14
(live BMDCs), 106 pulsed BMDCs that
were fixed with formaldehyde immediately
before injection (fixed BMDCs), 106 viable
thymocytes incubated with the same ratio
of bacteria (thymocytes) or, 106 BMDCs not
exposed to bacteria (live unpulsed BMDCs).
Sera samples were collected at day 14 and
serum titers of antigen specific Ig isotypes
were determined by ELISA. The data
show the arithmetic mean   SEM of the
individual titers.7 Colino et al.
sion of the IgG anti-PC response was also observed after
CTLA4Ig treatment, but this suppression was not absolute.
These data extend our previous observations in mice im-
munized with free S. pneumoniae alone (6, 22).
The Induction of Anti-PC and Anti-Cps14 Ig Responses by
S. pneumoniae–pulsed BMDCs Did Not Require BMDC Ex-
pression of MHC Class II Molecules and Were Not Associated
with BMDC Surface Presentation of Polysaccharide Epitopes.
To further understand the mechanism(s) underlying the T
cell–mediated induction of antiprotein and antipolysaccha-
ride responses to pulsed BMDCs we used BMDCs ob-
tained from mice genetically deficient in expression of
MHC class II molecules. As shown in Fig. 6, MHC class
II /  BMDCs pulsed with S. pneumoniae failed to induce
anti-PspA responses of any isotype upon transfer to naive
mice. In contrast, with the exception of IgG1, both anti-
PC and anti-Cps14 Ig responses to MHC class II /  and
wild-type pulsed BMDCs were similar (Fig. 6). The im-
pairment of the IgG1 response using MHC class II / 
Figure 4. Phagocyted bacteria are not the
immunogen by themselves. Groups of five
C57BL/6 mice were injected intravenously
with either 106 viable BMDCs pulsed with
S. pneumoniae type 14 (live BMDCs) or
pulsed BMDCs after three cycles of freeze-
thaw (freeze-thaw BMDCs). Serum samples
were collected at day 14 and serum titers of
antigen specific Ig isotypes were determined
by ELISA. The data show the arithmetic
mean   SEM of the individual titers.
Figure 5. Requirement for recipient T cells and B7–dependent co-
stimulation for pulsed BMDC induction of antigen-specific Ig isotypes.
Groups of seven C57BL/6 mice acutely depleted of T cells by treatment
with anti-CD4 and anti-CD8 mAbs (left), or blocked in their B7-depen-
dent interactions by treatment with CTLA4Ig (right) received an intrave-
nous injection of 106 BMDCs pulsed with S. pneumoniae type 14. The ti-
ters of antigen specific antibodies in the sera collected 14 d later were
compared with their respective controls, which were treated with an ir-
relevant IgG2b mAb, or a control fusion protein, respectively before in-
travenous injection with pulsed BMDCs. Statistically significant differ-
ences (P     0.05) between black and hatched bars are indicated by
asterisks (*). Statistically significant differences (P    0.05), between
hatched and white bars by dots (M).8 Dendritic Cells Induce Polysaccharide-specific Ig Responses
BMDCs was more marked for the Cps14-specific relative
to the PC-specific response. Flow cytometric analysis using
three anti-PC mAbs and one polyclonal anti-Cps14 mAb,
in BMDCs pulsed for 24 h with S. pneumoniae, failed to
detect either PC or Cps14 on the cell surface of pulsed
BMDCs, but did easily detect the presence of intracellular
PC (data not shown). These data argue against a direct
BMDCs surface presentation of B cell epitopes for the
polysaccharides studied.
BMDC Expression of CD40 or B7 Is Required for an Opti-
mal Anti-PspA Response, but Only for an Optimal IgG1 Anti-
polysaccharide Response. To further determine the costimu-
lation requirements for Ig induction in response to pulsed
BMDCs, we directly evaluated the importance of BMDC
expression of CD40 and B7–1/B7–2 by using BMDCs ob-
tained from mice genetically deficient in CD40, or mice
doubly deficient for B7–1 and B7–2. As shown in Fig. 7,
BMDCs lacking CD40, or B7 expression were markedly
defective in inducing anti-PspA responses of all isotypes rel-
ative to wild-type BMDCs. In contrast, BMDCs lacking in
these cell surface molecules were defective only in induction
of polysaccharide-specific IgG1. The differences in the IgG
anti-PC and anti-Cps 14 responses observed when using
CTLA4Ig (Fig. 5) versus B7-deficient BMDCs (Fig. 7), may
reflect either compensatory costimulatory ability of BMDCs
lacking B7, or more likely B7-dependent costimulation by
B cells and/or macrophages in the recipient. In this regard,
BMDCs derived from CD40 / , B7–1/B7–2 / , and
MHC class II /  mice, did not differ significantly in vitro,
in phagocytic capacity, cytokine secretion, or cell surface
phenotype relative to wild-type BMDCs (data not shown).
BMDC Production of IL-6 Is Required for Optimal Anti-
PspA and Antipolysaccharide Ig Responses. Finally, to deter-
mine whether BMDC-derived cytokines play a role in Ig
Figure 6. Requirements for
BMDC expression of MHC class II
molecules for induction of antigen-
specific Ig isotype responses. Groups
(n     5) C57BL/6 mice were in-
jected intravenous with 106 BMDCs
obtained from MHC class II / 
mice or 106 BMDCs obtained from
the corresponding background
C57BL/6 strain, both pulsed for 5 h
with  S. pneumoniae type 14. 14 d
later, serum Ig isotype titers specific
for PC, Cps14, and PspA were de-
termined by ELISA. Statistical sig-
nificance (P   0.05) is indicated by
asterisks (*).
Figure 7. BMDC expression of CD40
and B7 is required for an optimal antipro-
tein response, but only for an optimal IgG1
antipolysaccharide response. 106 BMDCs
obtained from CD40 / , B7–1 / /B7–2 / ,
or wild-type mice pulsed in vitro with S.
pneumoniae type 14 were injected intrave-
nous into separate groups of wild-type
mice. Serum antigen-specific Ig isotype ti-
ters 14 d after the injection were deter-
mined by ELISA. Statistically significant dif-
ferences (P     0.05) are indicated by
asterisks (*).9 Colino et al.
responses to S. pneumoniae, we used BMDCs obtained from
mice genetically deficient in TNF- , IL-6, IL-12, and IL-
10. IL-6 /  BMDCs showed a striking defect in the induc-
tion of IgG anti-PspA of all isotypes, and IgG1 and IgG2b
anti-Cps14, with a more modest reduction in IgG1 anti-PC
(Fig. 8). BMDCs lacking in IL-10 or TNF-  demonstrated
much more limited defects; IL-10 /  BMDCs elicited a
diminished IgG1 anti-PspA response relative to wild-
type  BMDCs whereas TNF-  /  BMDCs elicited re-
duced IgG2b anti-Cps14. A lack of IL-12 expression by
BMDCs had no significant effects on either the anti-PspA
or antipolysaccharide responses. BMDCs obtained from
TNF-  / , IL-6 / , or IL-12 /  mice did not differ sig-
nificantly from wild-type BMDCs in their in vitro phago-
cytic capacity, secretion of cytokines, and cell surface phe-
notype before or after exposure to S. pneumoniae (data not
shown). However, whereas IL-10 /  and wild-type BM-
DCs showed a similar cell surface phenotype before pulsing
with S. pneumoniae, exposure to bacteria resulted in a sig-
nificantly greater upregulation of MHC class II and CD86
in IL-10 /  BMDCs relative to wild-type BMDCs (2–3-
fold increase in MFI). Enhanced expression of MHC class
II and CD86 was also observed in cultures of wild-type,
pulsed BMDCs treated with a neutralizing anti–IL-10
mAb. Finally, addition of IL-10 to IL-10 /  pulsed BMDC
cultures reversed the increased enhancement of MHC class
II and CD86 relative to wild-type BMDCs (data not
shown). These data indicated that IL-10 downregulates
BMDC maturation in an autocrine manner.
Discussion
Little is known regarding the cellular mechanism(s) by
which intact extracellular bacteria elicit in vivo antipolysac-
charide, as well as antiprotein Ig isotype responses. The in-
ability of polysaccharide antigens to associate with MHC
molecules (2) and hence their failure to recruit cognate T
cell help for antipolysaccharide responses, has long called
into question the role, if any, of APCs, as well as T cells in
this process. Although polysaccharides may deliver potent
membrane Ig-mediated signals to the B cell, by virtue of
their multivalency, in vitro studies strongly suggest that ad-
ditional B cell signals are required for induction of Ig class
switching and secretion (1, 29).
It is well established that DCs can internalize both
Gram-positive and Gram-negative bacteria and can be
stimulated by these pathogens to undergo maturation and
cytokine secretion (11, 12, 30–32). However, the potential
role of DCs in mediating polysaccharide-, as well as pro-
tein-specific humoral responses in vivo, upon exposure to
an intact bacterial pathogen is unknown. In this regard, we
demonstrate that immature BMDCs not only mature and
secrete cytokines in response to the Gram-positive extra-
cellular bacteria, S. pneumoniae, but that such DCs internal-
ize nonopsonized S. pneumoniae and subsequently mediate
primary Ig responses specific for a bacterial-derived pro-
tein (PspA), lipoprotein (PsaA), capsular polysaccharide
(Cps14), and a haptenic component (PC) of the cell wall
C-polysaccharide (teichoic acid). Pulsed BMDCs also in-
duce immunologic memory which is most pronounced for
the antiprotein response. The mechanisms underlying
BMDC induction of protein- versus polysaccharide-spe-
cific Ig are distinct as will be discussed below.
The requirement for active participation, and hence po-
tential physiologic relevance, for BMDC induction of Ig in
response to intact S. pneumoniae, are underscored by the
demonstrated requirement for BMDC viability after bacte-
rial uptake and processing, cellular selectivity as evidenced
Figure 8. Role of BMDCs derived cytokines in
the induction of antiprotein and antipolysaccharide
antibody responses in vivo. 106 BMDCs obtained
from IL-6 / , IL-12 / , IL-10 / , TNF-  / , or
wild-type mice were pulsed with S. pneumoniae
type 14 and injected intravenous into wild-type
mice of the corresponding genetic background.
Sera were collected 14 d later for determination of
antigen-specific Ig isotype titers by ELISA. The as-
terisks (*) indicates statistically significant differ-
ences (P   0.05) for a particular isotype between
the antigen specific responses induced by cytokine-
deficient versus wild-type BMDCs.10 Dendritic Cells Induce Polysaccharide-specific Ig Responses
by the inability of viable thymocytes to similarly induce Ig,
the absence of BMDC cell surface retention of S. pneumo-
niae after a 24-h pulse, the poor immunogenicity of pulsed
BMDCs subjected to several freeze-thaw cycles before in-
jection, a strong requirement for BMDC secretion of IL-6,
and cell surface expression of MHC class II, CD40, and
B7–1/B7–2. Thus, passively carried intact bacteria, cell
membrane fragments containing MHC molecules loaded
with processed antigen, or cell debris containing partially
processed bacteria cannot account for BMDC induction of
the antigen-specific Ig responses. In this regard, DCs pulsed
with S. pneumoniae in vitro, then formalin-fixed, localized
to the spleen 1 h after intravenous injection at levels com-
parable to that seen using pulsed viable DCs (ratio 1:1.3
fixed: viable; data not shown). These data further support
the notion that passive DC-mediated transport of bacteria
to the spleen cannot account for the Ig-inducing activity of
viable pulsed DCs. However the transfer of antigen by in-
jected BMDCs to endogenous APCs for their subsequent
reprocessing and presentation could also be important in
the induction of the Ig response. This process could be me-
diated either through synapse formation with endogenous
APCs (33, 34) or exosome secretion by the injected BM-
DCs (35) as has been demonstrated in vitro.
In addition to a requirement for viable BMDCs, the pro-
tein- and polysaccharide-specific IgG responses induced by
pulsed BMDCs also share a requirement for T cells and B7-
dependent costimulation, whereas the IgM antipolysaccha-
ride response is relatively less dependent on these forms of
help. Cognate interactions between APCs and T cells result
in bidirectional signaling that is mediated by a number of
receptor–ligand pairs (36). Specifically, T cells become fully
activated through engagement of TCR with MHC–pep-
tide complexes on APCs, in concert with a costimulatory
signal typically, but not exclusively, delivered by the inter-
action of CD28 on the T cell with B7–1/B7–2 on the
APC. TCR cross-linking in turn, induces CD40-ligand on
the T cell which then can activate the APC through
CD40. This serves, in part, to upregulate B7 and MHC
molecules on the APC as well as costimulate release of in-
ductive cytokines making them more effective APCs for T
cells. In this regard, the absolute requirement for BMDC
expression of MHC class II, CD40, and B7–1/B7–2 for in-
duction of PspA-specific Ig of all IgG isotypes, collectively
support the notion that cognate DC–T cell interactions
play a critical role in mediating this response. Interestingly,
a similar pattern to that observed for induction of PspA-
specific Ig, including the induction of immunologic mem-
ory, was observed for the IgG1 anti-PC and anti-Cps14 re-
sponses. This strongly suggests that the induction of IgG1
antipolysaccharide responses by DCs, partly required cog-
nate DC–T cell help. That help may be mediated first
through the priming of T cells specific for bacterial protein
epitopes presented by the DCs. Polysaccharide-specific B
cells may then internalize bacteria or bacterial fragments
containing microbial protein and present MHC-peptide to
the primed T cells in order to receive cognate help. Of in-
terest, conjugation of polysaccharides to protein carriers
(e.g., “conjugate vaccines”) alters the antipolysaccharide re-
sponse from TI to TD and this is associated with a shift to
the IgG1 isotype and memory development (1, 37, 38).
In striking contrast, the IgG3 and IgG2b, as well as the
IgM, anti-PC, and anti-Cps14 responses are induced nor-
mally by pulsed BMDCs lacking either MHC class II,
CD40, or B7–1/B7–2. These data suggest the possibility
that the T cell help for the IgG3 and IgG2b antipolysaccha-
ride response is noncognate. In support of this, recent ob-
servations in our laboratory indicate a relatively rapid, B7-
dependent but TCR-nonspecific T cell helper activity for
the IgG anti-PC response to free S. pneumoniae in vivo (22,
39). Further, the lack of a requirement for BMDC expres-
sion of B7–1/B7–2 for the IgG3 and IgG2b antipolysac-
charide response, despite its inhibition by CTLA4Ig, sug-
gests that expression of B7 on other cell types, mostly likely
B cells and/or macrophages, can mediate the required T
cell costimulation.
BMDCs secreted both proinflammatory (IL-6, TNF- ,
and IL-12) and antiinflammatory (IL-10) cytokines with
distinctly different kinetics and duration after in vitro expo-
sure to S. pneumoniae, and this was mirrored at the tran-
scriptional level. Of note, TNF-  was secreted most rap-
idly, then quickly downregulated relative to the other
cytokines, suggesting that a major role in vivo of DC-
derived TNF- , as with TNF-  secreted by other myeloid
cells, is to activate the proinflammatory process in a para-
crine fashion. In light of the time during which BMDCs
were exposed in vitro to S. pneumoniae before being trans-
ferred into recipient mice, we anticipate that BMDCs re-
leased relatively little TNF-  during its elicitation of the Ig
response in vivo. Consistent with this, the Ig responses
elicited by TNF-  /  and wild-type BMDCs were essen-
tially similar. TNF-  has been reported to induce matura-
tion of BMDCs (40) and immature DC lines in vitro (31,
32), and perhaps serves to costimulate maturation of DCs
induced by bacteria. However, we observe that BMDCs
from TNF-  / , as well as from IL-6 /  and IL-12 / 
mice matured and secreted other cytokines normally in
vitro, relative to wild-type BMDCs.
In contrast, IL-10 in an autocrine fashion, limited
BMDC maturation in response to S. pneumoniae. Our ob-
servation that IL-10 released by BMDCs was delayed rela-
tive to IL-6, TNF- , and IL-12, suggests that this IL-10
serves to limit DC activation after its initiation by other
stimuli. IL-10 has also been shown by others to impair DC
induction of T cell responses and to induce antigen-specific
tolerance (41, 42). In this regard, the length of time during
which BMDCs were pulsed with S. pneumoniae in vitro be-
fore transfer into recipient mice, greatly limited their expo-
sure to artificially high levels of IL-10 in culture. Of inter-
est, IL-10 /  and wild-type BMDCs elicited similar Ig
responses in vivo, with the unexplained exception of the
IgG1 anti-PspA response, which was markedly reduced in
response to pulsed IL-10 /  BMDCs.
Pulsed BMDCs secreted IL-12 with kinetics similar to
IL-6. Of interest, BMDCs used in this study were of the
myeloid type (CD11c CD8  ), whereas lymphoid DCs11 Colino et al.
(CD11c CD8  ) appear to be the major source of IL-12
release in vivo in the systems studied (43). IL-12 plays a key
role in mediating a type 1 cytokine response, characterized
by IFN- , but not IL-4 production. Type 1 responses typi-
cally show a skewing of Ig toward the IgG2a isotype
whereas IL-4–dominated responses show a shift toward the
production of IgG1 (44). DCs have been implicated as a
key initial source of IL-12 for directing a subsequent type 1
response. Nevertheless, S. pneumoniae–pulsed BMDCs elic-
ited a mixed Ig isotype response suggesting a nonpolarized
pattern of cytokine production, and IL-12 /  and wild-
type BMDCs elicited similar Ig isotype responses in vivo.
The most dramatic effect of BMDC-derived cytokines
on the humoral response was seen with IL-6, as evidenced
by drastic impairments of both the antiprotein and anti-
polysaccharide responses using IL-6 / –pulsed BMDCs.
Specifically, marked reductions were observed in anti-PspA
of all IgG isotypes, IgG1 and IgG2b anti-Cps14, and IgG1
anti-PC. IL-6 could act directly on B cells to induce matu-
ration (45). In this regard, DCs have been reported to se-
crete soluble IL-6R  which, when complexed to IL-6
enhance the differentiation of CD40 activated B cells to
IgG-secreting cells (36). Alternatively, IL-6 may stimulate
humoral responses, through induction of C3 synthesis by
local macrophages (46). Antigen-bound C3 is important
for CD21-dependent B cell antigen receptor signaling, as
well as retention of antigen by follicular dendritic cells (47).
Of interest, a previous study has implicated DCs as a pri-
mary source of IL-6 during a TD Ig response in vivo (46).
The parameters governing the anti-Cps14 versus the
anti-PC responses were also somewhat different. Specifi-
cally, the anti-Cps14 response showed a greater depen-
dence on T cell help and B7-dependent costimulation, as
well as BMDC secretion of IL-6. Potentially relevant to
these differences is the fact PC is an environmental antigen
expressed by a broad range of commensal and pathogenic
microorganisms, as well as by host glycoconjugates (48),
whereas Cps14 is unlikely to be widespread in the envi-
ronment. Thus, B cells specific for PC, but not Cps14,
may be constitutively activated through their surface Ig re-
ceptors, and thus have less stringent activation require-
ments for induction of Ig isotype switching and maturation
into Ig-secreting cells.
In summary, our data are the first to demonstrate an ac-
tive role for DCs in the uptake and presentation of both
polysaccharide and protein antigens expressed by an intact
extracellular bacteria, for induction of a humoral response
in vivo. The distinctly different parameters involved
through which DCs mediate antiprotein and antipolysac-
charide responses, and even environmental versus nonen-
vironmental polysaccharides suggest novel pathways of
immune regulation and a powerful model system for their
further investigation. Of particular interest will be an elu-
cidation of how DCs process bacterial pathogens for the
eventual presentation of polysaccharide antigens to the
immune system.
We thank Drs. Andrew Lees and Luba Grinberg for providing
PC–KLH conjugates and the recombinant PspA and GM-CSF,
respectively.
This work was supported by NIH grants 1R01 AI49192 and
1R01 AI46551.
Submitted: 17 August 2001
Revised: 9 November 2001
Accepted: 14 November 2001
References
1. Mond, J.J., A. Lees, and C.M. Snapper. 1995. T cell-inde-
pendent antigens type 2. Annu. Rev. Immunol. 13:655–692.
2. Harding, C.V., R.W. Roof, P.M. Allen, and E.R. Unanue.
1991. Effects of pH and polysaccharides on peptide binding
to class II major histocompatibility complex molecules. Proc.
Natl. Acad. Sci. USA. 88:2740–2744.
3. Snapper, C.M., and J.J. Mond. 1996. A model for induction
of T cell-independent humoral immunity in response to
polysaccharide antigens. J. Immunol. 157:2229–2233.
4. Caulfield, M.J., and D. Stanko. 1995. T-cell dependent re-
sponse to immune complexes abrogates B-cell unresponsive-
ness to pneumococcal cell wall polysaccharide. Immunology.
86:331–335.
5. Breukels, M.A., G.T. Rijkers, M.M. Voorhorst-Ogink, and
B.J. Zegers. 1999. Regulatory T cells in the antibody re-
sponse to Haemophilus influenzae type b polysaccharide. Infect.
Immun. 67:789–793.
6. Wu, Z.Q., Q. Vos, Y. Shen, A. Lees, S.R. Wilson, D.E.
Briles, W.C. Gause, J.J. Mond, and C.M. Snapper. 1999. In
vivo polysaccharide-specific IgG isotype responses to intact
Streptococcus pneumoniae are T cell dependent and require
CD40-and B7-ligand interactions. J. Immunol. 163:659–667.
7. Hwang, Y.I., M.H. Nahm, D.E. Briles, D. Thomas, and J.M.
Purkerson. 2000. Acquired, but not innate, immune re-
sponses to Streptococcus pneumoniae are compromised by neu-
tralization of CD40L. Infect. Immun. 68:511–517.
8. Boswell, H.S., S.O. Sharrow, and A. Singer. 1980. Role of
accesory cells in B cell activation. I. Macrophage presentation
of TNP-Ficoll: evidence for macrophage-B cell interaction.
J. Immunol. 142:989–996.
9. Sinha, A.A., C. Guidos, K.C. Lee, and E. Diener. 1987.
Functions of accesory cells in B cell responses to thymus-
independent antigens. J. Immunol. 138:4143–4149.
10. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque,
Y. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology
of dendritic cells. Annu. Rev. Immunol. 18:767–811.
11. Inaba, K., M. Inaba, M. Naito, and R.M. Steinman. 1993.
Dendritic cell progenitors phagocytose particulates, including
bacillus Calmette-Guerin organisms, and sensitize mice to
mycobacterial antigens in vivo. J. Exp. Med. 178:479–488.
12. Leenen, P.J., K. Radosevic, J.S. Voerman, B. Salomon, N.
van Rooijen, D. Klatzmann, and W. van Ewijk. 1998. Het-
erogeneity of mouse spleen dendritic cells: in vivo phagocytic
activity, expression of macrophage markers, and subpopula-
tion turnover. J. Immunol. 160:2166–2173.
13. Svensson, M., B. Stockinger, and M.J. Wick. 1997. Bone
marrow-derived dendritic cells can process bacteria for
MHC-I and MHC-II presentation to T cells. J. Immunol.
158:4229–4236.
14. Inaba, K., J.P. Metlay, M.T. Crowley, and R.M. Steinman.
1990. Dendritic cells pulsed with protein antigens in vitro can
prime antigen-specific, MHC-restricted T cells in situ. J.12 Dendritic Cells Induce Polysaccharide-specific Ig Responses
Exp. Med. 172:631–640.
15. Ingulli, E., A. Mondino, A. Khoruts, and M.K. Jenkins.
1997. In vivo detection of dendritic cell antigen presentation
to CD4  T cells. J. Exp. Med. 185:2133–2141.
16. Wykes, M., A. Pombo, C. Jenkins, and G.G. MacPherson.
1998. Dendritic cells interact directly with naive B lympho-
cytes to transfer antigen and initiate class switching in a pri-
mary T-dependent response. J. Immunol. 161:1313–1319.
17. Berney, C., S. Herren, C.A. Power, S. Gordon, L. Martinez-
Pomares, and M.H. Kosco-Vilbois. 1999. A member of the
dendritic cell family that enters B cell follicles and stimulates
primary antibody responses identified by a mannose receptor
fusion protein. J. Exp. Med. 190:851–860.
18. Fernandez, N.C., A. Lozier, C. Flament, P. Ricciardi-Cast-
agnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E.
Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly
trigger NK cell functions: cross-talk relevant in innate anti-
tumor immune responses in vivo. Nat. Med. 5:405–411.
19. Mbow, M.L., N. Zeidner, N. Panella, R.G. Titus, and J.
Piesman. 1997. Borrelia burgdorferi-pulsed dendritic cells in-
duce a protective immune response against tick-transmitted
spirochetes. Infect. Immun. 65:3386–3390.
20. Su, H., R. Messer, W. Whitmire, E. Fischer, J.C. Portis, and
H.D. Caldwell. 1998. Vaccination against chlamydial genital
tract infection after immunization with dendritic cells pulsed
ex vivo with nonviable Chlamydiae. J. Exp. Med. 188:809–
818.
21. Alonso De Velasco, E., B.A. Dekker, A.F. Verheul, R.G.
Feldman, J. Verhoef, and H. Snippe. 1995. Anti-polysaccha-
ride immunoglobulin isotype levels and opsonic activity of
antisera: relationships with protection against Streptococcus
pneumoniae infection in mice. J. Infect. Dis. 172:562–565.
22. Wu, Z.Q., A.Q. Khan, Y. Shen, J. Schartman, R. Peach, A.
Lees, J.J. Mond, W.C. Gause, and C.M. Snapper. 2000.
B7 requirements for primary and secondary protein- and
polysaccharide-specific Ig isotype responses to Streptococcus
pneumoniae. J. Immunol. 165:6840–6848.
23. Briles, D.E., M. Nahm, K. Schroer, J. Davie, P. Baker, J.
Kearney, and R. Barletta. 1981. Antiphosphocholine anti-
bodies found in normal mouse serum are protective against
intravenous infection with type 3 Streptococcus pneumoniae. J.
Exp. Med. 153:694–705.
24. Wortham, C., L. Grinberg, D. Kaslow, D.E. Briles, L.S.
McDaniel, A. Lees, M. Flora, C.M. Snapper, and J.J. Mond.
1998. Enhanced protective antibody responses to PspA after
intranasal or subcutaneous injections of PspA genetically
fused to granulocyte-macrophage colony-stimulating factor
or interleukin-2. Infect. Immun. 66:1513–1520.
25. Pilling, P.A., M.C. Lawrence, A.M. Berry, A.D. Ogunniyi,
R.A. Lock, and J.C. Paton. 1998. Expression, purification
and preliminary X-ray crystallographic analysis of PsaA, a pu-
tative metal-transporter protein of Streptococcus pneumoniae.
Acta. Crystallogr. D. Biol. Crystallogr. 54:1464–1466.
26. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S.
Ikehara, S. Muramatsu, and R.M. Steinman. 1992. Genera-
tion of large numbers of dendritic cells from mouse bone
marrow cultures supplemented with granulocyte/macro-
phage colony-stimulating factor. J. Exp. Med. 176:1693–
1702.
27. Wallace, P.M., J.S. Johnson, J.F. MacMaster, K.A. Kennedy,
P. Gladstone, and P.S. Linsley. 1994. CTLA4Ig treatment
ameliorates the lethality of murine graft-versus-host disease
across major histocompatibility complex barriers. Transplanta-
tion. 58:602–610.
28. Vremec, D., G.J. Lieschke, A.R. Dunn, L. Robb, D. Met-
calf, and K. Shortman. 1997. The influence of granulocyte/
macrophage colony-stimulating factor on dendritic cell levels
in mouse lymphoid organs. Eur. J. Immunol. 27:40–44.
29. PeHanha, L.M., C.M. Snapper, F.D. Finkelman, and J.J.
Mond. 1991. Dextran-conjugated anti-Ig antibodies as a
model for T cell-independent type 2 antigen-mediated stim-
ulation of Ig secretion in vitro. I. Lymphokine dependence.
J. Immunol. 146:833–839.
30. McWilliams, A.S., S. Napoli, A.M. Marsh, F.L. Pemper, D.J.
Nelson, C.L. Pimm, P.A. Stumbles, T.N. Wells, and P.G.
Holt. 1996. Dendritic cells are recruited into the airway epi-
thelium during the inflamatory response to a broad spectrum
of stimuli. J. Exp. Med. 184:2429–2432.
31. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G.
Penna, L. Adorini, V. Zimmermann, J. Davoust, and P. Ric-
ciardi-Castagnoli. 1997. Maturation stages of mouse dendritic
cells in growth factor-dependent long-term cultures. J. Exp.
Med. 185:317–328.
32. Rescigno, M., S. Citterio, C. Thery, M. Rittig, D. Meda-
glini, G. Pozzi, S. Amigorena, and P. Ricciardi-Castaglioni.
1998. Bacteria-induced neo-biosynthesis, stabilization, and
surface expression of functional class I molecules in mouse
dendritic cells. Proc. Natl. Acad. Sci. USA. 95:5229–5234.
33. Batista, F.D., D. Iber, and M.S. Neuberger. 2001. B cells ac-
quire antigen from targetcells after synapse formation. Nature.
411:489–494.
34. Harshyne, L.A., S.C. Watkins, A. Gambotto, and S.M. Bar-
ratt-Boyes. 2001. Dendritic cells acquire antigens from live
cells for cross-presentation to CTL. J. Immunol. 166:3717–
3723.
35. Denzer, K., M. Eijk, M.J. Kleijmeer, E. Jakobson, C. Groot,
and H.J. Geuze. 2000. Follicular dendritic cells carry MHC
class II-expressing microvesicles at their surface. J. Immunol.
165:1259–1265.
36. Sperling, A.I., and J.A. Bluestone. 1996. The complexities of
T cell co-stimulation: CD28 and beyond. Immunol. Rev. 153:
155–182.
37. Jakobsen, H., B.C. Adarna, D. Schulz, R. Rappuoli, and I.
Jonsdottir. 2001. Characterization of the antibody response to
pneumococcal glycoconjugates and the effect of heat-labile
enterotoxin on IgG subclasses after intranasal immunization.
J. Infect. Dis. 183:1494–1500.
38. Lee, C.J., T.R. Wang, and C.E. Frasch. 2001. Immunoge-
nicity in mice of pneumococcal glycoconjugate vaccines us-
ing pneumococcal protein carriers. Vaccine. 19:3216–3225.
39. Snapper, C.M., Y. Shen, A.Q. Khan, J. Colino, P. Zela-
zowski, J.J. Mond, W.C. Gause, and Z. Wu. 2001. Distinct
types of T-cell help for the induction of a humoral immune
response to Streptococcus pneumoniae. Trends Immunol. 22:308–
311.
40. Brunner, C., J. Seiderer, A. Schlamp, M. Bidlingmaier, A.
Eigler, W. Haimerl, H.A. Lehr, A.M. Krieg, G. Hartmann,
and S. Endres. 2000. Enhanced dendritic cell maturation by
TNF-  or cytidine-phosphate-guanosine DNA drives T cell
activation in vitro and therapeutic anti-tumor immune re-
sponses in vivo. J. Immunol. 165:6278–6286.
41. Enk, A.H., J. Saloga, D. Becker, M. Mohamadzadeh, and J.
Knop. 1994. Induction of hapten-specific tolerance by inter-
leukin 10 in vivo. J. Exp. Med. 179:1397–1402.
42. Steinbrink, K., H. Jonuleit, G. Muller, G. Schuler, J. Knop,
and A.H. Enk. 1999. Interleukin-10-treated human dendritic13 Colino et al.
cells induce a melanoma-antigen-specific anergy in CD8  T
cells resulting in a failure to lyse tumor cells. Blood. 93:1634–
1642.
43. Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hert-
zog, and M. O’Keeffe. 2001. Differential production of IL-
12, IFN- , and IFN-  by mouse dendritic cell subsets. J. Im-
munol. 166:5448–5455.
44. Snapper, C.M., and W.E. Paul. 1987. Interferon-  and B cell
stimulatory factor-1 reciprocally regulate Ig isotype produc-
tion. Science. 236:944–947.
45. McGinnes, K., and C.J. Paige. 1991. Interleukins 1, 4 and 6
induce the colony formation of human bone marrow B lin-
eage cells. Eur. J. Immunol. 21:1271–1275.
46. Kopf, M., S. Herren, M.V. Wiles, M.B. Pepys, and M.H.
Kosco-Vilbois. 1998. Interleukin 6 influences germinal cen-
ter development and antibody production via a contribution
of C3 complement component. J. Exp. Med. 188:1895–1906.
47. Fearon, D.T., and M.C. Carroll. 2000. Regulation of B lym-
phocyte responses to foreign and self-antigens by the CD19/
CD21 complex. Annu. Rev. Immunol. 18:393–422.
48. Harnett, W., and M.M. Harnett. 1999. Phosphorylcholine:
friend or foe of the immune system? Immunol. Today. 20:
125–129.